A detailed history of Kestra Advisory Services, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 948 shares of UTHR stock, worth $340,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares
948
Previous 1,192 20.47%
Holding current value
$340,881
Previous $379,000 10.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $75,893 - $88,706
-244 Reduced 20.47%
948 $339,000
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $65,054 - $90,926
285 Added 31.42%
1,192 $379,000
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $191,159 - $226,305
907 New
907 $208,000
Q4 2022

Jan 31, 2023

BUY
$205.95 - $280.43 $202,242 - $275,382
982 New
982 $273,000
Q2 2022

Aug 12, 2022

BUY
$174.81 - $241.14 $183,900 - $253,679
1,052 New
1,052 $248,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.